Keystone eSymposia Logo

Joint meeting with NeuroImmune Interactions in Health and Disease

Neurodegenerative Diseases: Genes, Mechanisms and Therapeutics

June 7-9, 2021 | 9:00AM EDT | 1:00PM UTC | 3:00PM CEST*
*Program is in development and subject to change



 Attention


The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 9 months following the event.


 Free Access to On Demand Content to Scientists from Low-and Middle-Income Countries


Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest.


Apply Here


Neurodegenerative diseases, such as Alzheimer’s disease (AD) and AD-related disorders (ADRD) are quickly becoming a global burden. The number of diagnosed cases of neurodegenerative diseases is staggering and rising at an alarming rate as the population ages. While it is well-recognized that neurodegenerative diseases are characterized by aberrant protein misfolding and aggregate formation, the mechanisms that initiate or promote proteinopathy in disease-specific neural circuits remain poorly understood. Recent advances in human genetics and genome-wide association study (GWAS) have uncovered several genetic loci that are critical for the pathogenesis of neurodegenerative diseases. Furthermore, technological advances in transcriptomics, proteomics, and metabolomics offer many critical new insights into the disease mechanism, as well as opportunities for the development of novel therapeutics that can reverse or mitigate neurodegeneration. Despite these exciting new developments, there are significant gaps in connecting genetic information with disease mechanism and in harnessing the critical role of glia-neuron interactions to develop therapeutic interventions. 

This conference aims to provide an integrated discussion of the latest advances in research and therapeutic development for neurodegenerative diseases. This conference program will focus on the roles of genetic risk factors and their contributions to glial and neuronal health in the aging brain, the biophysical properties of protein misfolding and the propagation of disease-specific proteinopathy, the role of intracellular vesicular trafficking in disease pathogenesis, new insights into the diverse role of glia, innate immunity and microbiomes in neurodegeneration, and novel therapeutic approaches that specifically target each of the novel biological areas. It is anticipated that this conference will stimulate more discussions and promote new collaborations among scientists in the academia and industry that ultimately lead to new therapeutic targets to combat neurodegenerative diseases.

Apply Here for Free On Demand Access

Pricing:

Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD

Deadlines:

Abstract Submission
‣ For Short Talk Consideration: April 26, 2021
‣ For ePoster Presentation: May 24, 2021
Final ePoster / SciTalk Submission: May 27, 2021
Financial Aid Application: May 24, 2021

*Abstract submission is required in order to submit an ePoster and/or Scitalk

#VKSNeurodegen21


Financial Aid Opportunities

Graduate students and postdoctoral fellows, as well as individuals from low- and middle-income countries (all career stages) working in science and medicine-related fields, are eligible to apply for a FREE registration code.

Find out more about financial aid opportunities here!


Call For Abstracts

Showcase your work to global audiences on the eSymposia platform!

Submit your abstract by the Short Talk Deadline for the opportunity to be selected for a short talk presentation alongside field leaders on the meeting program!

ePoster presenters will be provided with their own dedicated abstract listing on the event website to display their work in multiple formats, and interact with meeting participants. ePoster features include:

  • Abstract Description
  • An embedded ePoster with an optional downloadable PDF
  • SciTalk – up to 5-minute video presentation, available on demand
  • A poster table at the Live Poster Session to present your work and answer audience questions in real-time
  • A chat function to speak with interested attendees and answer questions throughout the conference
  • Contact information for private follow-up discussion

To submit your work for an ePoster presentation, and to be considered for short talk selection, go to the “Submit an Abstract” tab on the event homepage.



Program Details



Keynote Speaker


22e10814e407d6aa9b68f3341e0517fa.png

Christopher K. Glass, MD, PhD
University of California, San Diego



Speaking at this eSymposia


Mathew M. Blurton-Jones

University of California, Irvine, USA


Anne Brunet

Stanford University, USA


Beverly L. Davidson

Children’s Hospital of Philadelphia and University of Pennsylvania, USA


Valina L. Dawson

Johns Hopkins University School of Medicine, USA


Philip L. De Jager

Columbia University Medical Center, USA


Ádám Dénes

Hungarian Academy of Sciences, Hungary


Fred H. Gage

The Salk Institute for Biological Studies, USA


Christopher K. Glass

University of California, San Diego, USA


Alison Goate

Icahn School of Medicine at Mount Sinai, USA


Michael T. Heneka

German Center for Neurodegenerative Diseases, Germany


Holly Kordasiewicz

Ionis Pharmaceuticals, USA


Virginia M. Y. Lee

University of Pennsylvania School of Medicine, USA


Joseph W. Lewcock

Denali Therapeutics, USA


Marco Prinz

University of Freiburg, Germany


Anne Schaefer

Mount Sinai School of Medicine, USA


Sjors Scheres

MRC Laboratory of Molecular Biology, UK


Lorenz Studer

Memorial Sloan Kettering Cancer Center, USA


Charlotte J. Sumner

Johns Hopkins School of Medicine, USA


J. Paul Taylor

St. Jude Children's Research Hospital, USA


Hui-Hsin Tsai

Biogen, USA


Li-Huei Tsai

Massachusetts Institute of Technology, USA


Jennifer Yokoyama

University of California, San Francisco, USA





Sponsors


sponsor-carousel-bluerock.png

Sponsor-Carousel-cell-research-red.png

sponsor-carousel-ionis.png

sponsor-carousel-genentech.png

Sponsor-Logo-ultragenyx-pharmaceutical.jpg




Additional Support



sponsor-carousel-NanoString.png

sponsor-Carousel-National-Institute-on-Aging.png

Funding for this conference was made possible (in part) by 1R13AG072818-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.




Media-in-Kind Support


sponsor-carousel-cellpress.png

sponsor-carousel-jcb-jem.png

sponsor-carousel-embo.png

sponsor-carousel-frontiers.png

Sponsor-Carousel-Leibert-Publishing.png

Sponsor-Carousel-nature-portfolio.png

 

sponsor-carousel-scientist.png

 





The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.






#ScienceMustGoOn



This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community.  Here, Debbie Johnson, our CEO, explains how we're going to do that.




Donate to Keystone Symposia


Donate to Keystone Symposia



Tags: